Late Breaker Abstract Submission Now Open!
CAHR is pleased to announce a call for Late-Breaking Scientific Abstracts for the 29th Annual Canadian Conference on HIV/AIDS Research (CAHR 2020). The purpose of offering late-breaking abstract submissions is to report recent, ground-breaking HIV research advanced with major impact to the field.
Please note that:
- research previously submitted on December 20th (open Abstract deadline) will not be accepted;
- case reports are not eligible for submission as late-breaking abstracts; and
- only a limited number of late breaker abstracts will be accepted as oral presentations.
The late breaker abstract submission will open Wednesday, February 26 and close Monday, March 16, 2020.
The CAHR 2020 Scientific Committee invites abstracts in the areas of Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. In addition, once again in 2020, you can request that your abstract be considered under a Key Populations session theme. Click on the link below to go directly to any of the following sections:
- Abstract Submission Guidelines and Policies
- Abstract Subjects
- Scholarships and Awards
- Abstract Presentation Guidelines and Policies
- Submit your Abstract
- Edit your submitted Abstract(s)
Abstract Submission Guidelines and Policies
Submission of an abstract acknowledges your consent to the following:
- If accepted, your abstract may be published in a scientific journal.
- If accepted as an oral presentation, your PPT presentation may be posted on the CAHR website post-conference.
- If accepted as a poster presentation, you will display your poster at the Conference.
- If requested by CAHR, you agree to prepare a “one-page media profile sheet” on your abstract for distribution to media.
- You agree to allow Rapporteurs to use all or part of your presentation or poster in the Rapporteur presentation at CAHR 2020.
Note: CAHR strives to promote excellence and innovation in HIV research in Canada. While CAHR welcomes all abstracts, those that offer new insights and are supported by researchers in Canadian universities, hospitals and other research institutions, are particularly encouraged.
Abstract Submission and Review Timeline
The deadline for abstract submission is Friday, December 20, 2019. The results of the peer review will be announced the week of February 24, 2020. The submitting author will be notified by email. Subsequent correspondence will be with the presenting author(s) only.
Presenting Author Registration
Presenting Authors must register to attend CAHR 2020. If you are not registered by the Presenting Author registration deadline of Monday, March 9, 2020, your abstract may not be included in the final program.
At the beginning of the abstract submission process, you will be asked to enter author information and affiliations.
Abstract Submitters and Presenters
CAHR strives to support the broadest numbers of researchers to participate in the Conference program. Any researcher who is submitting an abstract or presenting an abstract (oral or poster) must be a member of the research or investigation team.
Disclosure of Potential Conflict of Interest
If within the past five years, an author or immediate family member has had a substantial personal financial relationship relating to the support of the abstract, this relationship must be described. Such relationships include salaries, ownerships, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process, you will be asked to disclose any potential conflicts of interest. Find out more about CAHR’s Policy on Disclosure of Potential Conflicts of Interest.
Language of Abstract
Your abstract should be in English or French, and will be published in the language of submission.
Number of Submissions
There is a limit of two abstract submissions per presenting author.
Individual researchers are limited to presenting two abstracts during the conference program. Individual researchers may not, however, present more than one oral abstract per track. If the author wishes to submit more than two (2) abstracts, the additional abstracts should be submitted by another researcher on the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the conference program, that researcher may be listed as the presenter only once for an oral session and twice for posters.
Title and Abstract Length
The abstract title is limited to 140 characters. Please use Title Case (capital letters to start the principal words) for your abstract title instead of all CAPITAL or all small letters. Abstracts should be no more than 300 words in length, not including the title. Please note that abstracts will be truncated at 300 words in the Abstract Book if they run longer. Tables count as 50 words against the 300-word limit.
Please make sure you preview your abstract before submitting it. We recommend you print the preview and proof the printed copy.
Prepare your abstract in a word processing software such as MS Word or WordPerfect. Do not use presentation software such as PowerPoint. If you incorporate a data table in your abstract, the table counts as 50 words against your 300-word total.
Preferred Presentation Format
Please select one of the following presentation options during online abstract submission:
A limited number of oral presentations are available at CAHR 2020, and therefore many authors requesting an oral presentation cannot be accommodated. The Scientific Committee will note the author’s preference for an oral, but if not selected, authors will be offered a poster presentation instead.
Canadian Connection Policy
Scientific abstracts submitted for CAHR conference program must demonstrate a clear Canadian connection.
To demonstrate a Canadian connection, an abstract would need to meet at least one or more of these criteria:
- one or more investigators are based in Canada, are Canadian residents or trained in Canada
- one or more funders are based in Canada, i.e. a Canadian funder, or other national or international funder (organization or individual) that is based in or operating in Canada
- one or more Canadian scientific research or other organizations based in Canada is involved or partnered in the research project
- at least some of the research population is resident in Canada
- at least some of the research activity is conducted in Canada
- the research builds extensively on existing Canadian research
- the evidence from the research is relevant, wholly or partially, to current issues and challenges specific to the HIV/AIDS response in Canada
- other connection such as the research was initiated, proposed or promoted by Canadian researcher(s) or institution(s).
Abstract Submission from outside of Canada
Over the last several years, there has been an alarming increase in the number of plagiarized abstracts submitted to the CAHR conference. Due to this unfortunate situation, and in an effort to reduce the burden on abstract reviewers and conference organizers, abstracts submitted from individuals who reside outside of Canada will be required to briefly describe the Canadian connection (as described above) and provide a Canadian HIV academic researcher as a reference to verify their work.
- HIV Virology (Viral and Host Factors)
- Immunology of HIV and Vaccines
- HIV Pathogenesis and Animal Models
- Host Genetics and Viral Evolution
- Antivirals, Microbicides and Mechanisms of HIV Resistance
- Eradication Strategies Towards an HIV Cure
- HIV Latency and Viral Reservoirs
- Comorbidities, Coinfections and Complications
- Biomarkers and Diagnostics
- Clinical Trials and Observational Studies of Antiretrovirals and Other HIV Therapies
- Co-infections (including HCV, HBV, HPV, TB)
- STDs (Chlamydia, Gonorrhea, Syphilis)
- Complications of Antiretroviral Therapy
- Early Treatment and Cure
- HIV and Aging and Comorbidities (including CVD, Osteoporosis, Neurocognitive Effects)
- HIV in Children and Adolescents
- HIV in Key Populations and Global Health Issues: Clinical Aspects
- HIV in Women and in Pregnancy
- HIV Prevention: Clinical Aspects
- Mental Health Issues and HIV Positive Persons
- Opportunistic Infections and Malignancies
- Pharmacology, Pharmacokinetics and Pharmacoeconomics
- Substance Use and HIV
- Chemsex and HIV transmission
Epidemiology and Public Health Sciences
- Data and Methodological Science: use of administrative data, new tools and other novel data sources in HIV surveillance, prevention and control programs
- Economic Evaluation of Public Health Policies, Programs or Interventions
- Epidemiology and Surveillance of HIV Co-infections
- Evaluations of Public Health Policies, Programs or Interventions
- HIV in Priority Populations and Global Health Issues: Epidemiology and Public Health Aspects
- HIV Prevention: Public Health Aspects
- HIV Prevention and Control Programs Towards Key Populations –Implementation and Program Science
- Indigenous HIV Prevention and Control Programs – Implementation and Program Science
- Interdisciplinary Epidemiology (Biological, Behavioural and Social) of HIV infection, including structural, social and individual determinants
- Process Advances and Lessons Learned in Complex or Community-based Public Health Research
- Public Health Ethics
- Indigenous Health
- The Health of African, Caribbean and Black Communities
- Living with HIV and Health
- Gay, Bisexual and other Men who have Sex with Men (MSM)
- Communities of People Who Use Drugs and HIV
- Diversities of Gender and Sexual Expression: Identities and Contexts
- Young People’s Health
- Trans and Nonbinary Communities
- Intersecting Identities and HIV
- Critical Social Theory: Advancements (in Understanding the HIV Epidemic)
- Social, Structural and Systemic Drivers of HIV
- Criminalization, Law and Policy
- Combining Prevention Strategies: Social Science Perspectives
- Behavioral and Social Intervention and Implementation Research
- Programming and Policy
- Models of Care and Improving Access
- Impacts of Migration within Canada on Health
- Responding to the Opioid Crisis
- U = U
- Engaging (with) Communities in HIV Research
- Arts-Based Approaches to HIV Research
The CAHR 2020 Scientific Committee invites abstracts in the areas of: Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. In addition you can request that your abstract be considered under a “Key Populations” session theme. By indicating your interest in participating in a Key Populations session, you agree to tailor your presentation to an audience from all tracks. Please note that indicating your interest here does not preclude your abstract from being accepted for your selected track sessions.
Community driven and culturally responsive approaches to harm reduction, sexual health, and HIV care cascades for the following key populations:
- African, Caribbean and Black people
- Indigenous communities
- Sexual and gender minorities
- People who use drugs
Scholarships and Awards
Academic Scholarships as well as New Investigator Awards will be presented to selected candidates. For application details, visit the Scholarships & Awards page. Please note that you must apply for scholarships and awards when submitting your abstract.
Abstract Presentation Guidelines and Policies
CAHR strives to support the broadest number of researchers to participate in the Conference program. Any researcher who is submitting an abstract or presenting an abstract (oral or poster) must be a member of the research or investigation team. Individual researchers are limited to presenting two abstracts per researcher during the conference program. Individual researchers may not, however, present more than one oral abstract per track. If the author wishes to submit more than two (2) abstracts, the additional abstracts should be submitted by another researcher as part of the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only once for an oral session or twice for abstract posters.
The oral presentations are scheduled on Friday, May 1, Saturday, May 2 and Sunday, May 3, 2020. You will be notified about your presentation time once your abstract is accepted as an oral presentation. Oral presentations are 10 minutes in length, and will be followed by 5 minutes for questions and answers. New Investigator Awards applicants will be reviewed during their presentation, and the awards recipients announced at the Closing ceremonies of the Conference.
Posters will be presented on Friday, May 1 and Saturday, May 2, 2020. Information on poster viewing times, poster size, set-up and removal will be included in the abstract notification email.
Submit your Abstract(s)
Click HERE to submit your abstract.
Edit your submitted Abstract(s)
You can only edit your abstract until the abstract submission deadline.
Please email your questions on abstract submission to firstname.lastname@example.org.